Some domestic players trying to get customs duty hiked: association
“The growth in imports of medical devices is being purposely exaggerated by a section of the domestic manufacturers to suit their agenda of seeking a hike in customs duty,” noted a release issued by the Medical Technology Association of India (MTaI), which represents research-based medical technology companies in India. The association noted that a section of the domestic manufacturers were presenting the value of imports of 2018-19 as being 25% higher than the previous year. “The numbers are being presented in rupee terms, which is an erroneous measure as the value of rupee has depreciated sharply and therefore it does not present the correct picture. During the fiscal 2018-19, there was a sharp decline in INR to the extent of about 15% at its peak and if a full year’s average is considered, the rupee depreciated by 8.5% in fiscal 2018-19 over the previous fiscal. Therefore, data in rupee terms is not comparable because of the effect of depreciating currency. One has to study the figures in US dollar to deduce a logical conclusion,” it said. He added that a look at the import data from Export-Import Data Bank on Department of Commerce’s website made things amply clear. Imports under Chapter 90 that contains all medical devices, grew 19.82% in 2018-19 from a year earlier when expressed in rupee terms. However, the corresponding growth in US$ terms was only 10.45%. “The fact is after the GST regime, importers have to pay respective customs duty which is around 7.5%-10% in addition to 12% of GST. So in effect, importers are paying more taxes after the GST regime than before. It is true that the input tax credit is applicable against GST component on inputs, but the same is available for locally manufactured goods as well. In total, GST regime does not benefit importers in any way over domestic players. In fact, post-GST import duties on many implantable devices have gone up to 10% due to increase in custom duties,” said MTaI director Sanjay Bhutani.
Check Also
National Monetisation Pipeline (NMP)
Unlocking Value in Infrastructure The NMP is a government initiative launched in the 2021-22 Union …